The United States Cystic Fibrosis Foundation released the first guideline on newborn screening for cystic fibrosis (CF), in order to improve timely detection of CF in infants from all racial and ...
The United States Cystic Fibrosis Foundation released the first guideline on newborn screening for cystic fibrosis (CF), in order to improve timely detection of CF in infants from all racial and ...
These organizations and the experts they employ play a critical role in advancing the development of safe and effective ...
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $478.12, a high ...
Vertex halts VX-264 trials after missing efficacy goals but continues advancing zimislecel, a potential treatment for severe ...
Despite a $400 million impairment charge, analysts say the removal of a drug-device combo from its portfolio is not a huge ...
But her career arc slowly bent back toward that childhood revelation. Today, Stueland is the CEO of GeneDx, a publicly traded ...
Vertex Pharmaceuticals is flexing its innovation muscles beyond its cystic fibrosis stronghold, charging into new territories ...
Vertex Pharmaceuticals is marching beyond its cystic fibrosis stronghold with bold steps into pain management and genetic ...
Vertex Pharmaceuticals today announced that ... for the treatment of cystic fibrosis to include children aged 2-5 years who have at least one F508del mutation in the cystic fibrosis transmembrane ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback